Xbiotech Inc
(XBIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,921 | 12,019 | 15,823 | 20,849 | 24,849 |
| TOTAL | $45,599 | $12,982 | $17,016 | $21,306 | $25,766 |
| Non-Current Assets | |||||
| PPE Net | 26,276 | 26,842 | 27,329 | 27,938 | 28,524 |
| TOTAL | $26,276 | $26,842 | $27,329 | $27,938 | $28,524 |
| Total Assets | $71,875 | $39,824 | $44,345 | $49,244 | $54,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,550 | 1,861 | 1,653 | 878 | 1,455 |
| Accrued Expenses | 912 | 980 | 1,291 | 1,422 | 1,301 |
| TOTAL | $2,462 | $2,841 | $2,944 | $2,300 | $2,756 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 3 | 7 | 12 |
| TOTAL | $N/A | $N/A | $3 | $7 | $12 |
| Total Liabilities | $2,462 | $2,841 | $2,947 | $2,307 | $2,768 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,011 | 36,113 | 36,048 | 35,820 | 35,820 |
| Common Shares | 319,045 | 280,664 | 279,353 | 278,879 | 278,441 |
| Retained earnings | -249,416 | -243,564 | -237,700 | -231,589 | -226,538 |
| Other shareholders' equity | -216 | -117 | -255 | -353 | -381 |
| TOTAL | $69,413 | $36,983 | $41,398 | $46,937 | $51,522 |
| Total Liabilities And Equity | $71,875 | $39,824 | $44,345 | $49,244 | $54,290 |